ClinicalTrials.Veeva

Menu

Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Not yet enrolling

Conditions

Surgical Wound

Treatments

Device: Wound Vacuum-Assisted Closure (VAC)
Device: Fish Skin Graft (FSG)

Study type

Interventional

Funder types

Other

Identifiers

NCT06910189
HSC-MS-24-1100

Details and patient eligibility

About

The purpose of this study is to estimate the effect of FSG (Kerecis) on hospital length of stay among adult patients with surgical wounds of at least 40cm2 requiring surgical debridement

Enrollment

96 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Has wound greater than or equal to 40cm2 requiring surgical debridement
  • Agreeable to follow up period of up to 1 year

Exclusion criteria

  • Patients with wounds that do not require surgical debridement.
  • Patients with a known allergy or other sensitivity to fish material
  • Patients who are deemed unlikely to follow up (e.g., patients who live out of state).
  • Patients in police custody/incarcerated.
  • Patients unable to communicate in either Spanish or English.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

96 participants in 2 patient groups

Fish Skin Graft arm and Vacuum-Assisted Closure
Experimental group
Treatment:
Device: Fish Skin Graft (FSG)
Device: Wound Vacuum-Assisted Closure (VAC)
Vacuum-Assisted Closure only
Active Comparator group
Treatment:
Device: Wound Vacuum-Assisted Closure (VAC)

Trial contacts and locations

1

Loading...

Central trial contact

Jonah Stulberg, MD; Debbie Lew

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems